Elevance Health (ELV) Stock
NEW YORK STOCK EXCHANGE INC. · ELV
395.27
Fundamentals
Market cap
$85.90B
Price / Earnings ratio
17.4x
Price / Sales ratio
0.4x
Price / Book ratio
1.9x
Return on assets
4.0%
Ex-Dividend date
10 Sep 2026
Last payment date
25 Sep 2026
Dividend amount
$1.72
Dividend yield
1.73%
Debt / Equity ratio
N/A
Recent news

Zacks Investment Research
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
NeutralELVSeptember 16, 2026
Zacks Investment ResearchNeutral
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
ELV

Zacks Investment Research
ELV or DHR: Which Is the Better Value Stock Right Now?
NeutralELVSeptember 15, 2026
Zacks Investment ResearchNeutral
ELV or DHR: Which Is the Better Value Stock Right Now?
ELV

Zacks Investment Research
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
NeutralELVAugust 25, 2026
Zacks Investment ResearchNeutral
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
ELV

Zacks Investment Research
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
NeutralELVAugust 14, 2026
Zacks Investment ResearchNeutral
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
ELV
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral3
Buy7
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2022
2023
2024
2025
239B158B79B0
Debt & Balance Sheet
Total assets
Total liabilities
2022
2023
2024
2025
146B96B48B0
Revenue to Profit
2025$199.1B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$5.7B
Net incomeEarnings
EPS forecast
Actual EPS
$8.84
$9.19
Q2FY25
$6.03
$4.96
Q3FY25
$3.14
Q4FY25
$10.35
Q1FY26
$7.96
Q2FY26
The market is expecting earnings per share of $7.96 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

Zacks Investment Research
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
NeutralELVSeptember 16, 2026
Zacks Investment ResearchNeutral
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
ELV

Zacks Investment Research
ELV or DHR: Which Is the Better Value Stock Right Now?
NeutralELVSeptember 15, 2026
Zacks Investment ResearchNeutral
ELV or DHR: Which Is the Better Value Stock Right Now?
ELV

Zacks Investment Research
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
NeutralELVAugust 25, 2026
Zacks Investment ResearchNeutral
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
ELV

Zacks Investment Research
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
NeutralELVAugust 14, 2026
Zacks Investment ResearchNeutral
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
ELV

Business Wire
Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
NeutralELVJuly 30, 2026
Business WireNeutral
Elevance Health Strengthens Connected Cancer Care Model to Support Consumers Through Their Health Journey
ELV

24/7 Wall Street
Billionaire Investor Seth Klarman's Top 5 Stocks: Would He Buy More Today?
NeutralELVJuly 25, 2026
24/7 Wall StreetNeutral
Billionaire Investor Seth Klarman's Top 5 Stocks: Would He Buy More Today?
ELV

The Motley Fool
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?
NeutralELVJuly 20, 2026
The Motley FoolNeutral
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?
ELV

The Motley Fool
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?
NeutralELVJuly 17, 2026
The Motley FoolNeutral
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?
ELV

Zacks Investment Research
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues
NeutralELVJuly 15, 2026
Zacks Investment ResearchNeutral
ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues
ELV

MarketBeat
Elevance Health Q2 Earnings Call Highlights
NeutralELVJuly 15, 2026
MarketBeatNeutral
Elevance Health Q2 Earnings Call Highlights
ELV
About Elevance Health
Elevance Health brings together the concepts of elevate and advance, exemplified by our bold purpose of improving the health of humanity. We are a health company dedicated to making real progress toward improving the health of the people and communities we serve.
SectorHealthcare
IndustryHealthcare Plans
Employees96,129
CEOMs. Gail Koziara Boudreaux
IPO DateJan 2, 2001
HeadquartersIndianapolis, IN
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Gail Koziara Boudreaux | President, CEO & Director | 1961 |
| Mr. Mark Bradley Kaye | Executive VP & CFO | 1980 |
| Mr. Peter David Haytaian Esq. | Special Advisor | 1970 |
| Mr. Charles Morgan Kendrick Jr. | EVP and President of Commercial & Specialty Health Benefits | 1966 |
| Ms. Felicia Farr Norwood | Executive VP & Chief Health Benefits Officer | 1960 |
| Mr. Scott Wayne Anglin | SVP, Treasurer & Chief Investment Officer | — |
| Mr. Ronald William Penczek | Senior VP, Controller & Chief Accounting Officer | 1965 |
| Mr. Nathan Allen Rich | Vice President of Investor Relations | — |
| Ms. Erin M. Wessling | Executive VP & Chief Legal Officer | 1978 |
| Ms. Julie Goon | Senior Vice President of Public Affairs | — |
Fundamentals
Valuation
Market cap$85.90B
Price-to-sales ratio0.43
Price-to-book value1.92
Price-earnings ratio17.40
Return on Equity12.00%
Return on Sales4.00%
Return on Assets4.00%
PEG ratio1.30
Earnings Per Share
Earnings Per Share$22.64
Income Statement
Average volume1,151,410
EBITDA$9.16B
1 year high (52w)$436.24
1 year low (52w)$274.84
Dividend
Ex dividend date10 Sep 2026
Dividend amount$1.72
Dividend yield1.73%
Last payment date25 Sep 2026
Dividend yield (TTM)1.74%
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
10 Wall Street Analyst Ratings
BUY
70% Buy
30% Hold
0% Sell
Target price
$447.50
Est return
12.98%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -4.1 | +15.7 | -5.3 | +14.6 | ||||||||
| 2022 | -5.1 | +3.0 | +8.8 | +0.5 | +2.5 | -3.3 | -1.8 | +3.0 | -7.3 | +16.3 | -2.1 | -2.3 |
| 2023 | -0.4 | -5.8 | -2.0 | -1.6 | -5.2 | -4.3 | +6.1 | -5.5 | -1.6 | +2.2 | +7.4 | -2.4 |
| 2024 | +3.1 | +1.2 | +3.9 | +2.4 | +2.6 | -0.2 | -0.5 | +4.6 | -7.5 | -20.6 | -1.7 | -10.1 |
| 2025 | +8.2 | -2.0 | +10.0 | -2.8 | -6.0 | +3.2 | -28.5 | +16.0 | +0.2 | -4.6 | +8.0 | +6.3 |
| 2026 | -2.4 | -6.4 | -0.4 | +26.1 | +5.5 | -4.0 | -9.7 | +2.6 | -1.7 |
Corporate actions
Upcoming
No upcoming corporate actions for ELV
Past
DividendQ3/26
Ex-dividend date10 Sep 2026
Payable date25 Sep 2026
Amount per share$1.72
DividendQ2/26
Ex-dividend date10 Jun 2026
Payable date25 Jun 2026
Amount per share$1.72
DividendQ1/26
Ex-dividend date10 Mar 2026
Payable date25 Mar 2026
Amount per share$1.72
DividendQ4/25
Ex-dividend date5 Dec 2025
Payable date19 Dec 2025
Amount per share$1.71
DividendQ3/25
Ex-dividend date10 Sep 2025
Payable date25 Sep 2025
Amount per share$1.71
DividendQ2/25
Ex-dividend date10 Jun 2025
Payable date25 Jun 2025
Amount per share$1.71
DividendQ1/25
Ex-dividend date10 Mar 2025
Payable date25 Mar 2025
Amount per share$1.71
DividendQ4/24
Ex-dividend date5 Dec 2024
Payable date20 Dec 2024
Amount per share$1.63
DividendQ3/24
Ex-dividend date10 Sep 2024
Payable date25 Sep 2024
Amount per share$1.63
DividendQ2/24
Ex-dividend date10 Jun 2024
Payable date25 Jun 2024
Amount per share$1.63
DividendQ1/24
Ex-dividend date7 Mar 2024
Payable date22 Mar 2024
Amount per share$1.63
DividendQ4/23
Ex-dividend date5 Dec 2023
Payable date21 Dec 2023
Amount per share$1.48
DividendQ3/23
Ex-dividend date7 Sep 2023
Payable date22 Sep 2023
Amount per share$1.48
DividendQ2/23
Ex-dividend date8 Jun 2023
Payable date23 Jun 2023
Amount per share$1.48
DividendQ1/23
Ex-dividend date9 Mar 2023
Payable date24 Mar 2023
Amount per share$1.48
DividendQ4/22
Ex-dividend date2 Dec 2022
Payable date21 Dec 2022
Amount per share$1.28
DividendQ3/22
Ex-dividend date8 Sep 2022
Payable date23 Sep 2022
Amount per share$1.28
DividendQ2/22
Ex-dividend date9 Jun 2022
Payable date24 Jun 2022
Amount per share$1.28
DividendQ1/22
Ex-dividend date9 Mar 2022
Payable date25 Mar 2022
Amount per share$1.28



